The insulin‐like growth factor I system in cerebellar degeneration
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Brain insulin‐like growth factor I (IGF‐I) and its related molecules may be involved in neurodegenerative processes in which IGF‐I‐containing pathways are compromised. Since IGF‐I is present in the olivocerebellar circuitry, two types of late‐onset cerebellar ataxias (olivopontocerebellar and idiopathic cerebellar cortical atrophy) were chosen to test this hypothesis. The following significant changes in the peripheral IGF‐I system of these patients were found: low IGF‐I levels, and high IGF‐binding protein 1 (BP‐1), and BP‐3 affinity for IGF‐1. Sixty percent of the patients also had significantly low insulin levels. Patients suffering from other neurological diseases with cerebellar dysfunction and ataxia not involving the olivocerebellar pathway also had low IGF‐I levels, while IGFBPs and insulin levels were normal. Our data indicate that degeneration of an IGF‐I‐containing neuronal pathway produces significant changes in the peripheral IGF system. This suggests strongly that the endocrine (bloodborne) and the paracrine/autocrine (brain) IGF systems are linked functionally. We propose that alterations in the blood IGF‐I system may constitute a marker of some cerebellar diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Insulin and insulin-like growth factors in the CNS
Baskin, D. G., Wilcox, B. J., Figlewicz, D. P., & Dorsa, D. M. (1988) · Trends in Neurosciences · doi:10.1016/0166-2236(88)90155-5 · Cited by 330
Komoly, S., Hudson, L. D., Webster, H. D., & Bondy, C. A. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.5.1894 · Cited by 223
Cited by
Perluigi, M., di Domenico, F., Fiorini, A., Cocciolo, A., Giorgi, A., Foppoli, C., Butterfield, D. A., Giorlandino, M., Giorlandino, C., Eugenia Schininà, M., et al. (2011) · PROTEOMICS – Clinical Applications · doi:10.1002/prca.201000121 · Cited by 97
“The present findings extend and reinforce the observation that levels of circulating insulin, IGF-I and IGFBPs are altered in many types of human neurodegenerative diseases, including major illnesses such as Alzheimer disease or stroke as well as inherited neurodegenerative diseases [55, 56].”
ResultCho, Z., Oh, S., Kim, J., Park, S., Kwon, D., Jeong, H., Kim, Y., Chi, J., Park, C., Huston, J., et al. (2011) · Movement Disorders · doi:10.1002/mds.23465 · Cited by 87
Carrascosa, C., Espejo, L., Torrado, S., & Torrado, J. J. (2003) · Journal of Biomaterials Applications · doi:10.1177/088532803038026 · Cited by 44
“It is well known that brain concentration of IGF-I and its related molecules are involved in neurodegenerative processes in which IGF-I containing pathways are compromised, such as cerebellar ataxia, among others [11,12].”
BackgroundKAFFASHIAN, M., SHABANI, M., GOUDARZI, I., BEHZADI, G., ZALI, A., & JANAHMADI, M. (2011) · Physiological Research · doi:10.33549/physiolres.932032 · Cited by 16
Metadata
- Authors
- Torres‐Aleman, I., Barrios, V., Lledo, A., & Berciano, J.
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 1996-03
- Volume
- 39
- Issue
- 3
- Pages
- 335-342
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- OpenAlex
- W2053140251
- Cited by
- 56
- References
- 2
- FWCI
- 1.41
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The insulin‐like growth factor I system in cerebellar degeneration. https://app.cochat.ai/papers/10.1002/ana.410390310
- The paper
- Torres‐Aleman, I., Barrios, V., Lledo, A., & Berciano, J. (1996). The insulin‐like growth factor I system in cerebellar degeneration. Annals of Neurology. https://doi.org/10.1002/ana.410390310
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.